Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$9.60
+1.9%
$8.67
$7.11
$11.90
$1.29B1.641.29 million shs382,320 shs
CareDx, Inc. stock logo
CDNA
CareDx
$19.44
+0.8%
$17.62
$13.81
$34.84
$1.08B2.18905,859 shs96,544 shs
CRH Medical Corporation stock logo
CRHM
CRH Medical
$3.99
$3.99
$1.66
$4.01
$285.76MN/A1.04 million shs388,486 shs
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$29.78
+2.4%
$27.87
$21.18
$37.13
$1.03B1.51225,796 shs16,654 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
+4.55%+11.08%+1.18%-11.47%-4.07%
CareDx, Inc. stock logo
CDNA
CareDx
+0.94%+1.37%+9.42%+7.41%+37.69%
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00%0.00%0.00%0.00%0.00%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
-0.21%+3.67%+2.61%+18.20%+28.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.8256 of 5 stars
3.51.00.00.02.71.73.8
CareDx, Inc. stock logo
CDNA
CareDx
4.1705 of 5 stars
3.32.00.04.22.00.81.9
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
3.1375 of 5 stars
2.34.00.00.03.22.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.00
Buy$13.4039.60% Upside
CareDx, Inc. stock logo
CDNA
CareDx
2.67
Moderate Buy$30.3356.08% Upside
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00
N/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.60
Moderate Buy$34.6016.20% Upside

Current Analyst Ratings Breakdown

Latest CRHM, AHCO, CDNA, and PNTG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$35.00
6/3/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$30.00 ➝ $31.00
5/12/2025
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
5/12/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$28.00 ➝ $32.00
5/8/2025
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$14.00 ➝ $13.00
5/5/2025
CareDx, Inc. stock logo
CDNA
CareDx
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$40.00 ➝ $40.00
5/5/2025
CareDx, Inc. stock logo
CDNA
CareDx
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$25.00 ➝ $25.00
4/17/2025
CareDx, Inc. stock logo
CDNA
CareDx
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$34.00 ➝ $26.00
4/2/2025
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$38.00 ➝ $38.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.26B0.40$4.03 per share2.38$11.72 per share0.82
CareDx, Inc. stock logo
CDNA
CareDx
$333.79M3.24$1.38 per share14.05$7.06 per share2.75
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$695.24M1.48$0.94 per share31.62$9.08 per share3.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$90.42M$0.5716.849.901.042.63%6.96%2.40%8/5/2025 (Estimated)
CareDx, Inc. stock logo
CDNA
CareDx
$52.55M$1.1516.90N/AN/A19.79%21.16%14.25%7/30/2025 (Estimated)
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/A0.00N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$22.56M$0.7639.2233.842.483.40%10.73%4.00%8/5/2025 (Estimated)

Latest CRHM, AHCO, CDNA, and PNTG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
CareDx, Inc. stock logo
CDNA
CareDx
$0.06$0.09+$0.03-$0.19$84.56 million$84.69 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
CareDx, Inc. stock logo
CDNA
CareDx
N/AN/AN/AN/AN/A
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.25
1.29
1.07
CareDx, Inc. stock logo
CDNA
CareDx
N/A
4.11
3.84
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.81
1.41
1.41

Institutional Ownership

CompanyInstitutional Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
CareDx, Inc. stock logo
CDNA
CareDx
N/A
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%

Insider Ownership

CompanyInsider Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.55%
CareDx, Inc. stock logo
CDNA
CareDx
4.40%
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,500134.95 million132.86 millionOptionable
CareDx, Inc. stock logo
CDNA
CareDx
74055.68 million53.23 millionOptionable
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A71.62 millionN/ANot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
7,00034.47 million32.61 millionOptionable

Recent News About These Companies

Pennant Group appoints new board director

New MarketBeat Followers Over Time

Media Sentiment Over Time

AdaptHealth stock logo

AdaptHealth NASDAQ:AHCO

$9.60 +0.18 (+1.90%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

CareDx stock logo

CareDx NASDAQ:CDNA

$19.43 +0.15 (+0.75%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

The Pennant Group stock logo

The Pennant Group NASDAQ:PNTG

$29.78 +0.69 (+2.36%)
As of 11:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.